ClinicalTrials.Veeva

Menu

Spaulding-Harvard Model System: Effects of Transcranial Direct Current Stimulation (tDCS) on Chronic Pain in Spinal Cord Injury

Mass General Brigham logo

Mass General Brigham

Status

Completed

Conditions

Neuropathic Pain
Chronic Pain
Spinal Cord Injury

Treatments

Device: Transcranial direct current stimulation (tDCS)

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT01599767
2011-p-002353

Details and patient eligibility

About

The purpose of this study is to see the effects of transcranial direct current stimulation (tDCS) on the pain associated with spinal cord injury. This study is part of the Spaulding-Harvard Model System. The investigators hypothesize that there will be a decrease in pain levels with active stimulation, when compared to sham stimulation, using a 3 week stimulation schedule- 1 week of stimulation (5 consecutive days) followed by 2 weeks of stimulation (10 consecutive days) after a 3-month follow up visit. The subject will also have follow ups at 2, 4 and 8 weeks after the second course of stimulation.

If a subject receives sham during the experiment, he/she may enroll in an open-label portion of the study and receive 10 days of active stimulation.

Enrollment

46 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Over 18 years of age
  • History of moderate to severe sublesional pain

Exclusion criteria

  • Active alcohol or drug dependence, as self-reported
  • A history of bipolar disorder or psychosis, as self-reported
  • Inability to travel to the study site,
  • Current use of any of the following anti-epileptic medications or dopaminergic medications known to reduce or inhibit the benefits of tDCS treatment [53]: carbamazepine, oxcarbazepine, phenytoin, ropinirole (Requip), pramipexole (Mirapex), and cabergoline (Dostinex),
  • The following contradictions to tDCS: implanted metal plates in the head, or deep brain stimulator (spinal cord implants, including baclofen pumps, are not a contraindication as cranial currents do not reach the spinal cord [24]).
  • Pregnancy at time of enrollment
  • Current use of ventilator.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

46 participants in 2 patient groups

Active tDCS
Experimental group
Description:
Subjects will undergo 20 minutes active tDCS.
Treatment:
Device: Transcranial direct current stimulation (tDCS)
Sham tDCS
Sham Comparator group
Description:
Subjects will undergo 20 minutes of sham stimulation.
Treatment:
Device: Transcranial direct current stimulation (tDCS)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems